Authors and Disclosures
Léna Rivard, MD, MSc, Leif Friberg, MD, PhD, David Conen, MD, MPH, Jeffrey S. Healey, MD, MSc*, Trygve Berge, MD, PhD, Giuseppe Boriani, MD, PhD, Axel Brandes, MD, DMSc, Hugh Calkins, MD*, A. John Camm, MD*, Lin Yee Chen, MD, Josep Lluis Clua Espuny, MD, PhD, Ronan Collins, MD, Stuart Connolly, MD, Nikolaos Dagres, MD, Mitchell S.V. Elkind, MD, MSc, Johan Engdahl, MD, PhD, Thalia S. Field, MD, MHSc, Bernard J. Gersh, MB, ChB, DPhil, Taya V. Glotzer, MD, Graeme J. Hankey, MD, Joseph A. Harbison, MD, FD, Karl Georg Haeusler, MD, Mellanie T. Hills, BSc, Linda S.B. Johnson, MD, PhD, Boyoung Joung, MD, PhD, Paul Khairy, MD, PhD, Paulus Kirchhof, MD, Derk Krieger, MD, PhD, Gregory Y.H. Lip, MD, Maja-Lisa Løchen, MD, PhD, Malini Madhavan, MBBS, Georges H. Mairesse, MD, Joan Montaner, MD, PhD, George Ntaios, MD, MSc, Terence J. Quinn, MD, Michiel Rienstra, MD, PhD, Mårten Rosenqvist, MD, PhD*, Roopinder K. Sandhu, MD, MPH, Breda Smyth, MD, Renate B. Schnabel, MD, MSc*, Stavros Stavrakis, MD, PhD, Sakis Themistoclakis, MD, Isabelle C. Van Gelder, MD, PhD, Ji-Guang Wang, MD, PhD* and Ben Freedman, MBBS, PhD*
Montreal Heart Institute, Université de Montréal, Canada (L.R., P. Khairy). Karolinska Institute, Stockholm, Sweden (L.F., M.R.). Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (D.C., J.S.H., S.C.). Vestre Viken Hospital Trust, Norway (T.B.). Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Italy (G.B.). Odense University Hospital, Denmark (A.B.). Johns Hopkins University, Baltimore, MD (H.C.). Cardiovascular Clinical Academic Group, St Georges Hospital, London, UK (A.J.C.). University of Minnesota, Minneapolis (L.Y.C.). Catalonian Health Institute, Spain (J.L.C.E.). Tallaght Hospital, Dublin, Ireland (R.C.). Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Germany (N.D.). Columbia University, New York (M.S.V.E.). Karolinska Institutet, Department of Clinical Sciences, Danderyds Hospital, Stockholm, Sweden (J.E.). University of British Columbia, Vancouver Stroke Program, Canada (T.S.F.). Mayo Clinic, Rochester, MN (B.J.G.). Hackensack University Medical Centre, NJ (T.V.G.). Medical School, Faculty of Health and Medical Sciences, The University of Western Australia (G.J.H.). Trinity College, Dublin, Ireland (J.H.). Department of Neurology, Universitätsklinikum Würzburg, Germany (K.G.H.). StopAfib.org, Decatur, TX (M.T.H.). Lund University, Sweden (L.J.). Yonsei University College of Medicine, Seoul, South Korea (B.J.). University Heart and Vascular Center UKE Hamburg, Germany (P. Kirchhof). German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Germany (P. Kirchhof). Institute of Cardiovascular Sciences, University of Birmingham, UK, and AFNET, Münster, Germany (P. Kirchhof). University Hospital of Zurich, Switzerland (D.K.). Aalborg University, Denmark (G.Y.H.L.). Department of Community Medicine, UiT The Arctic University of Norway, Tromsø (M.L.L.). Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (M.M.). Cliniques du Sud Luxembourg, Arlon, Belgium (G.H.M.). Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain (J.M.). Stroke Research Program, Institute of Biomedicine of Seville, Spain (J.M.). IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville, Spain (J.M.). Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain (J.M.). University of Thessaly, Greece (G.N.). University of Glasgow, Glasgow Royal Infirmary, UK (T.J.Q.). University of Groningen, University Medical Center Groningen, the Netherlands (M.R., I.C.V.G.). Cedars-Sinai, Los Angeles, CA (R.K.S.). Department of Public Health, Health Service Executive West, Galway, Ireland (B.S.). University Heart Centre, Hamburg, Germany (R.B.S.). University of Oklahoma Health Sciences Center, Oklahoma City (S.S.). Ospedale dell'Angelo Venice-Mestre, Venice, Italy (S.T.). Jiaotong University School of Medicine, China (J.G.W.). Charles Perkins Centre and Concord Hospital Cardiology, University of Sydney, Australia (B.F.).
Correspondence to
Léna Rivard, MD, MSc, Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada. Email lena. rivard@umontreal.ca
*AF-SCREEN International Collaboration Steering Committee member
Disclosures
Dr Rivard reports research grants from Bayer Inc, Heart and Stroke Foundation, and FRSQ (Fonds de Recherche Santé du Québec). Dr Berge reports speaker fees from Bayer, Boehringer Ingelheim, BMS, and Pfizer. Dr Boriani reports speaker's fees of small amounts from Bayer, Boehringer, Boston, and Medtronic. Dr Brandes reports research grants from the Region of Southern Denmark and Theravance and has been a speaker for Bayer, Boehringer Ingelheim, BMS/Pfizer, and MSD. Dr Camm reports consulting fees from Bayer, Daiichi Sankyo, Boehringer Ingelheim, Boston Scientific, and Abbott; and research funding from Bayer, Daiichi Sankyo, Boehringer Ingelheim, Pfizer BMS, Boston Scientific, and Abbott. Dr Conen holds a McMaster University Department of Medicine Mid-Career Research Award and reports honoraria from Servier Canada and Roche Diagnostics, both outside of the current work. Dr Elkind reports receiving study drug in kind from the BMS-Pfizer Alliance for Eliquis® and ancillary funding from Roche for an National Institutes of Health–funded trial of stroke prevention; royalties from UpToDate; and serving as an unpaid Officer of the American Heart Association. Dr Engdahl reports lecture or consultant fees from Pfizer, Bristol Myers Squibb, Merck Sharpe & Dome, Medtronic, Boehringer Ingelheim, and Roche Diagnostics. Dr Hankey reports personal fees from the American Heart Association (as Associate Editor for Circulation) and speaker and consulting fees from Bayer and Medscape. Dr Häeusler reports speaker honoraria, consulting fees, lecture honoraria, and/or study grants from Abbott, AstraZeneca, Bayer, Biotronik, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Edwards Lifescience, Medtronic, Pfizer, Portola, Premier Research, Sanofi, and WL Gore and Associates. Dr Wang reports research grants from National Natural Science Foundation of China (grants 91639203 and 82070435), Beijing, and the Shanghai Commission of Science and Technology (grant 19DZ2340200), Shanghai, China, and lecture and consulting fees from Novartis, Omron, Servier, and Takeda. Dr Kirchhof is partially supported by European Union BigData@Heart (grant agreement EU IMI 116074 and Horizon 2020 AFFECT-EU, 847770), British Heart Foundation (FS/13/43/30324; PG/17/30/32961 and PG/20/22/35093; AA/18/2/34218), German Center for Cardiovascular Research supported by the German Ministry of Education and Research (DZHK), and Leducq Foundation; has received honoraria from companies active in atrial fibrillation and cognitive function in the past, but not in the past 3 years; and is listed as inventor on 2 patents held by the University of Birmingham (Atrial fibrillation therapy WO 2015140571 and Markers for atrial fibrillation WO 2016012783). Dr Lip reports honoraria from Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon, and Daiichi-Sankyo and speaking for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo; no fees are directly received personally. Dr Madhavan reports a significant research grant from BMS/Pfizer. Dr Montaner reports research funding from Fundación Marató de TV3: "Atrial Fibrillation Research in Catalonia (AFRICAT): Sequential Clinic-Electro-Biological Screening Among High Risk Individuals," code 20152830, and H2020 program (AFFECT-EU grant agreement 847770) for digital, risk-based screening for atrial fibrillation in the European community. Dr Ntaios reports speaker fees/advisory boards/research support from Abbott, Amgen, Bayer, Boehringer-Ingelheim, BMS, and Pfizer. Drs Rienstra and Van Gelder report research grants from the Netherlands Cardiovascular Research Initiative: An Initiative With Support of the Dutch Heart Foundation: CVON 2014–9: Reappraisal of Atrial Fibrillation: Interaction Between Hypercoagulability, Electric Remodelling, and Vascular Destabilisation in the Progression of AF (RACE V) and grant support from Medtronic to the institution outside this work. Dr Sandhu reports research grants from Servier and BMS/Pfizer. Dr Schnabel reports research grants from the European Research Council under the European Union's Horizon 2020 research and innovation program under grant agreements 648131 and 847770 (AFFECT-EU), the German Center for Cardiovascular Research (DZHK eV; 81Z1710103), the German Ministry of Research and Education (BMBF 01ZX1408A), and ERACoSysMed3 (031L0239) and has received lecture fees and advisory board fees from BMS/Pfizer outside this work. The other authors report no conflicts.